샘플 요청 목록

 카트 문의
시장보고서
상품코드
1559473

세계 단백질 칩 시장 - 인사이트, 경쟁 구도, 시장 예측(2030년)

Protein Chip - Market Insights, Competitive Landscape, and Market Forecast - 2030
발행일: | 리서치사: DelveInsight | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

세계의 단백질 칩 시장 규모는 2024-2030년의 예측 기간에 CAGR로 6.73%의 성장이 예상됩니다. 암, 당뇨병, 심혈관장애 등 만성질환의 유병률 증가는 이러한 질환을 보다 잘 이해하고 새로운 치료법을 개발하기 위한 연구개발 활동이 높아짐에 따라 단백질칩 시장 을 견인합니다. 또한 다양한 임상 연구에서 단백질 칩이 제공하는 다양한 용도도 2024-2030년의 예측 기간에 시장 성장을 가속하는 요인이 되고 있습니다.

단백질 칩 시장 역학

Global Cancer Observatory가 제공한 최신 데이터에 따르면 2022년 세계에서 새롭게 발생한 암 환자수는 2,000만명으로 추정되며, 2045년까지 3,260만명으로 증가할 것으로 예측되고 있습니다. 또한 이 데이터에 따르면 유럽에서의 신규암 환자수는 447만명으로 2045년까지 548만명으로 증가할 것으로 예측되고 있습니다. 게다가 British Heart Foundation(2024년)이 제공한 최근의 데이터에 따르면 2021년에 전 세계적으로 약 6억 2,000만 명이 심혈관 질환을 앓고 있었습니다.

또한, International Diabetes Federation이 제공한 최근 데이터에 따르면 2021년에 약 5억 3,700만 명의 성인(20-79세)이 당뇨병을 앓고 있었습니다. 당뇨병 환자의 총 수는 2030년까지 6억 4,300만 명, 2045년까지 7억 8,300만 명으로 증가할 것으로 예측됩니다.

따라서 암, 당뇨병, 심혈관 질환과 같은 만성 질환의 유병률 증가는 주로 의료 연구 개발에서의 사용 증가로 단백질 칩 시장을 크게 강화합니다. 다수의 단백질을 동시에 분석할 수 있는 단백질 칩은 연구자가 분자 수준에서 질병 메커니즘을 연구하는 강력한 도구입니다. 이를 통해 신규 바이오마커의 식별이 용이해지고 조기 진단 및 표적 요법의 개발이 가능합니다. 또한, 높은 처리량 스크리닝을 수행하는 단백질 칩의 능력은 신약 후보의 효능과 안전성을 신속하게 평가할 수 있도록 신약 및 연구 개발 프로세스를 가속화하기 위해 단백질 칩 시장을 밀어 올립니다.

그러나 질 수량 분석, 차세대 시퀀싱, 웨스턴 블로팅과 같은 대체 기술의 사용과 단백질 상호 작용의 복잡성은 단백질 칩 시장의 성장에 약간의 장애를 초래할 수 있습니다.

단백질 칩 시장의 부문 분석

단백질 칩 시장의 용도 부문에서는 2023년에 유전체학 단백질체학 카테고리가 단백질 칩 시장에서 큰 수익 점유율을 차지할 것으로 추정됩니다. 유전체학 단백질체학 용도는 단백질 바이오칩 시장의 성장과 이점을 촉진하는 데 도움이 됩니다. 유전체학는 질병과 관련된 유전자 변이의 동정을 가능하게 하고, 맞춤형 치료의 개발과 바이오마커의 발견을 선도합니다. 한편, 단백질체학는 단백질의 발현, 구조, 기능에 대한 지식을 제공하며, 질병 메커니즘과 약물 치료 대상의 이해에 필수적입니다. 높은 처리량 단백질 분석을 가능하게 하는 단백질 바이오칩은 여러 단백질의 신속하고 동시 검출을 가능하게 함으로써 함께 유전체학 단백질체학의 연구에 필수적입니다. 이 통합은 진단 정확도를 높이고, 약물을 촉진하고, 개인화된 의료 활동을 지원합니다.

이 성장은 단백질체학와 유전체학의 응용 분야에서 단백질 바이오칩 기술의 지속적인 진보와 공동 연구에 의해 더욱 추진되어, 질병 진단을 보다 빠르고, 보다 신뢰성이 높고, 보다 이용하기 쉽게 함으로써 세계 안의 임상 현장이나 연구실에서의 채용이 퍼지고 있습니다. 예를 들어 2022년 9월 Illumina Inc.는 NovaSeq X 시리즈를 출시하여 보다 빠르고 강력한 지속 가능한 시퀀싱을 가능하게 했습니다. 획기적인 신기술인 NovaSeq X Plus는 연간 20,000개가 넘는 전체 유전체을 생성할 수 있어 유전체 탐색과 임상 고려사항을 가속화하고 환자의 삶을 변화시킵니다. 따라서 세계의 이러한 발전은 지역 바이오칩 시장의 성장을 가속하고 있습니다. 그 결과 단백질 바이오칩에 대한 수요가 증가하고 연구와 임상 환경 모두에서 시장 성장과 채용이 촉진될 것으로 예측됩니다.

따라서 위의 요인에 따라 유전체학 단백질체학 카테고리가 큰 성장을 보일 것으로 예상됩니다. 이 성장은 예측 기간 동안 단백질 칩 시장 전체를 견인합니다.

이 보고서는 세계의 단백질 칩 시장에 대한 조사 분석을 통해 각 지역 시장 규모와 예측, 지난 3년간의 제품/기술 개발, 각 부문의 성과 및 전망 등의 정보를 제공합니다.

목차

제1장 단백질 칩 시장 보고서 소개

제2장 단백질 칩 시장의 주요 요약

  • 시장 개요

제3장 경쟁 구도

제4장 규제 분석

  • 미국
  • 유럽
  • 일본
  • 중국

제5장 단백질 칩 시장의 주요 요인 분석

  • 단백질 칩 시장 성장 촉진요인
  • 단백질 칩 시장 성장 억제요인과 과제
  • 단백질 칩 시장의 기회

제6장 단백질 칩 시장의 Porter's Five Forces 분석

제7장 단백질 칩 시장 평가

  • 기술별
    • 분석용 단백질 마이크로어레이
    • 기능성 단백질 마이크로어레이
    • 역상 단백질 어레이
  • 용도별
    • 유전체학·단백질체학
    • 창약
    • 항체 특성 평가
  • 최종 사용자별
    • 제약 기업, 생명 공학 기업
    • 학술, 연구기관
  • 지역
    • 북미
    • 유럽
    • 아시아태평양
    • 기타 지역

제8장 단백질 칩 시장의 기업과 제품 프로파일

  • Agilent Technologies, Inc.
  • RayBiotech, Inc.
  • Sengenics Corporation LLC.
  • CDI Labs.
  • Creative Biolabs
  • Proteintech Group, Inc
  • RayBiotech Life Inc.
  • QUOTIENT LIMITED
  • PerkinElmer Inc.
  • Merck KGAA
  • Illmina Inc.
  • Arrayit Corporation
  • Spectrum Solutions
  • ACROBiosystems
  • Sengenics Corporation LLC

제9장 KOL의 견해

제10장 프로젝트 접근법

제11장 DelveInsight 정보

제12장 면책사항 및 문의

JHS 24.10.02

Protein Chips Market By Technology (Analytical Protein Microarrays, Functional Protein Microarrays, And Reverse-Phase Protein Arrays), Applications (Genomics & Proteomics, Drug Discovery, And Antibody Characterization), End-Users (Pharmaceutical & Biotechnology Companies, And Academic & Research Institutions), And Geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady CAGR forecast till 2030 owing to the growing prevalence of chronic disorders, growing applications of protein biochips in various clinical research studies

The protein chips market is estimated to grow at a CAGR of 6.73% during the forecast period from 2024 to 2030. The increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders will drive the market for protein chips as there is a growing research and development efforts to understand these diseases better and develop new treatments. Additionally, various applications provided by protein chips in various clinical research studies, is another contributing factor propelling the market growth during the forecast period from 2024 to 2030.

Protein Chips Market Dynamics

According to the latest data provided by the Global Cancer Observatory, in 2022, the estimated number of new cancer cases globally was 20 million, with projections indicating a rise to 32.6 million cases by 2045. Additionally, as per the same source the new cases of cancer in Europe was 4.47 million, with projection estimating a rise to 5.48 million cases by 2045. Additionally, as per the recent data provided by British Heart Foundation (2024), in 2021 there were around 620 million people living with cardiovascular disease globally.

Furthermore, as per the recent data provided by the International Diabetes Federation, in 2021 approximately 537 million adults (20-79 years) were living with diabetes. The total number of people living with diabetes was projected to rise to 643 million by 2030 and 783 million by 2045.

Therefore, the growing prevalence of chronic conditions like cancer, diabetes, and cardiovascular diseases considerably enhances the market for protein chips, mainly due to their increasing usage in healthcare research and development. Protein chips, with their capability to analyze numerous proteins simultaneously, provide a powerful tool for researchers to study disease mechanisms at a molecular level. This facilitates the identification of novel biomarkers, enabling early diagnosis and the development of targeted therapies. Furthermore, the ability of protein chips to conduct high-throughput screenings accelerates drug discovery and development processes, allowing researchers to quickly assess the efficacy and safety of new drug candidates thereby boosting the market of protein chips.

However, the use of alternative technologies such as mass spectroscopy, next generation sequencing, western blotting, and complexity in protein interaction may result in slight obstacle to the growth of protein chips market.

Protein Chips Market Segment Analysis:

Protein Chips Market by Technology (Analytical Protein Microarrays, Functional Protein Microarrays, and Reverse-Phase Protein Arrays), Applications (Genomics & Proteomics, Drug Discovery, and Antibody Characterization), End-Users (Pharmaceutical & Biotechnology Companies and Academic & Research Institutions), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the application segment of the protein chip market, the genomics and proteomics category is estimated to mass a significant revenue share in the protein chips market in 2023. The application of genomics and proteomics has been instrumental in driving the growth and dominance of the protein biochip market. Genomics enables the identification of genetic variations associated with diseases, guiding the development of personalized therapies and the discovery of biomarkers. Proteomics, on the other hand, provides insights into the expression, structure, and function of proteins, crucial for understanding disease mechanisms and drug targets. Protein biochips, which allow for high-throughput protein analysis, are integral to both genomics and proteomics research by enabling rapid and simultaneous detection of multiple proteins. This integration enhances diagnostic accuracy, facilitates drug discovery, and supports personalized medicine initiatives, thereby expanding the protein biochip market significantly.

The growth is further propelled by ongoing advancements and collaborations in protein biochip technology in the field of proteomics and genomics applications, making disease diagnosis faster, more reliable, and more accessible, thereby broadening their adoption in clinical settings and research laboratories worldwide. For instance, In September 2022, Illumina Inc. launched the NovaSeq X Series, enabling faster and more powerful sustainable sequencing. The revolutionary new technology, NovaSeq X Plus could generate 20,000+ whole genomes per year, therefore accelerating genomic discovery and clinical insights to transform patient lives. Thus, such developments across the globe are driving the growth of the biochips market in the region. As a result, the demand for protein biochips is expected to increase, driving market growth and adoption in both research and clinical settings.

Accordingly, based on the factors mentioned above, the genomics and proteomics category is expected to experience significant growth. This growth will drive the overall protein chips market during the forecast period.

North America Is Expected To Dominate The Overall Protein Chips Market:

North America is expected to account for the highest proportion of the protein chips market in 2023, out of all regions. One of the primary drivers is the escalating prevalence of chronic disease such as cancer and cardiovascular. Additionally, the presence of major pharmaceutical and biotechnology players in the region, along with the presence of advanced research and development infrastructure. Further, increasing collaborations between academia, research institutions, and biotechnology companies are some of the factors propelling the growth of the protein chips market in North America.

According to recent data from the GLOBOCAN, in 2022, North America saw an estimated 2.67 million new cases of cancer, with forecasts indicating a rise to 3.83 million by 2045. As per the same source, in Canada, the number of new cancer cases was around 292,000 in 2022, projected to reach 449,000 by 2045. Meanwhile, in Mexico, there were approximately 207,000 new cases of cancer in 2022, expected to increase to 360,000 by 2045.

Additionally, as per the recent data provided by British Heart Foundation (2024), in 2021 there were around 48 million people living with cardiovascular disease in North America.

According to the latest report provided by the Centre of Disease Control and Prevention, in 2021 estimates indicated that 38.4 million people of all ages, or 11.6% of the U.S. population, had diabetes. Additionally 38.1 million individuals aged 18 years and older, representing 14.7% of all U.S. adults, were affected by diabetes in 2021.

As the surge of chronic disorders increases there is a significant increase in the research and development efforts to understand these diseases better and develop new treatments. Protein chips are crucial in this research as they allow for high-throughput analysis of protein interactions and functions, accelerating discoveries and innovations.

The growth is further propelled by ongoing acquisitions among the companies in protein biochip technology. For instance, in March 2023, Spectrum Solutions(R) acquired Alimetrix, Inc., a lab accredited by CLIA and CAP that specializes in creating custom diagnostic tests, and Microarrays, Inc., a company known for its array-based biological research tools like gene expression and protein arrays. Thus, this expanded product portfolio will cater to a wider range of applications in both biological research and clinical diagnostics, thereby increasing market reach.

Thus, the above mentioned factors are expected to escalate the market of protein chips in North America during the forecast years.

Protein Chips Market Key Players:

Some of the key market players operating in the Protein Chips market include Agilent Technologies, Inc., RayBiotech, Inc., Sengenics Corporation LLC., CDI Labs., Creative Biolabs., Proteintech Group, Inc, RayBiotech Life Inc., QUOTIENT LIMITED, PerkinElmer Inc., Merck KGAA, Illumina Inc., Arrayit Corporation, Spectrum Solutions, ACROBiosystems, Sengenics Corporation LLC, and others.

Recent Developmental Activities In The Protein Chips Market:

  • In January 2024, Agilent Technologies launched the ProteoAnalyzer system, an advanced automated system for protein analysis using parallel capillary electrophoresis. This new platform makes it easier and more efficient to analyze complex protein mixtures. It is useful in various fields, including pharmaceuticals, biotechnology, food analysis, and academic research.
  • In December 2023, Theralink Technologies announced groundbreaking research by George Mason University and the University of California, San Francisco, published in Cell Reports Medicine. The study used Theralink's RPPA (reverse phase protein array) technology to analyze tumors from over 700 breast cancer patients. It discovered a protein biomarker called HARPS, which can help better treat Triple Negative Breast Cancer (TNBC) by identifying appropriate therapies, leading to an 80% response rate compared to the current 30-40%.

Key Takeaways From The Protein Chips Market Report Study

  • Market size analysis for current protein chips size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
  • Key companies dominating the protein chips market.
  • Various opportunities available for the other competitors in the protein chips market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current protein chips market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for protein chips market growth in the coming future?

Target Audience Who Can Be Benefited From This Protein Chips Market Report Study

  • Protein chips product providers
  • Research organizations and consulting companies
  • Protein chips -related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in protein chips
  • Various end-users who want to know more about the protein chips market and the latest technological developments in the protein chips market.

Frequently Asked Questions For The Protein Chips Market:

1. What are protein chips?

Protein chips, also known as protein microarrays, are sophisticated laboratory tools designed to study a vast array of proteins simultaneously. These chips consist of a solid surface, typically a glass slide or membrane, onto which thousands of different proteins are immobilized. They facilitate the high-throughput analysis of protein expression, interactions, activities, and functions, making them invaluable in various fields such as biomarker discovery, drug development, disease diagnostics, and functional proteomics.

2. What is the market for Protein Chips?

The protein chips market is estimated to grow at a CAGR of 6.73% during the forecast period from 2024 to 2030.

3. What are the drivers for the protein chips market?

The demand for protein chips is primarily being boosted by the growing prevalence of chronic diseases like cancer, diabetes, and cardiovascular disorders. Additionally, growing applications of protein biochips in various clinical research studies is another major driver for the growth of the protein chips market during the forecast years.

4. Who are the key players operating in the protein chips market?

Some of the key market players operating in the protein chips are Agilent Technologies, Inc., RayBiotech, Inc., Sengenics Corporation LLC., CDI Labs., Creative Biolabs., Proteintech Group, Inc, RayBiotech Life Inc., QUOTIENT LIMITED, PerkinElmer Inc., Merck KGAA, Illumina Inc., Arrayit Corporation, Spectrum Solutions, ACROBiosystems, Sengenics Corporation LLC, and others.

5. Which region has the highest share in the protein chips market?

North America is expected to account for the highest proportion of the protein chips market in 2023, out of all regions. One of the primary drivers is the escalating prevalence of chronic disease such as cancer and cardiovascular. Additionally, the presence of major pharmaceutical and biotechnology players in the region, along with the presence of advanced research and development infrastructure. Further, increasing collaborations between academia, research institutions, and biotechnology companies are some of the factors propelling the growth of the protein chips market in North America.

Table of Contents

1. Protein Chips Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Protein Chips Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Protein Chips Market Key Factors Analysis

  • 5.1. Protein Chips Market Drivers
    • 5.1.1. Growing prevalence of chronic disease
    • 5.1.2. Growing applications of protein biochips in various clinical research studies
  • 5.2. Protein Chips Market Restraints and Challenges
    • 5.2.1. The use of alternative technologies
    • 5.2.2. Complexity in protein interaction
  • 5.3. Protein Chips Market Opportunities
    • 5.3.1. Ongoing research & developmental activities pharmaceuticals for the treatment of chronic diseases

6. Protein Chips Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Protein Chips Market Assessment

  • 7.1. By Technology
    • 7.1.1. Analytical Protein Microarrays
    • 7.1.2. Functional Protein Microarrays
    • 7.1.3. Reverse-Phase Protein Arrays
  • 7.2. By Application
    • 7.2.1. Genomics & Proteomics
    • 7.2.2. Drug Discovery
    • 7.2.3. Antibody Characterization
  • 7.3. By End-user
    • 7.3.1. Pharmaceutical and Biotechnology Companies
    • 7.3.2. Academic and Research Institutions
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States Protein Chips Market Size in USD Million (2021-2030)
      • 7.4.1.2. Canada Protein Chips Market Size in USD Million (2021-2030)
      • 7.4.1.3. Mexico Protein Chips Market Size in USD Million (2021-2030)
    • 7.4.2. Europe
      • 7.4.2.1. France Protein Chips Market Size in USD Million (2021-2030)
      • 7.4.2.2. Germany Protein Chips Market Size in USD Million (2021-2030)
      • 7.4.2.3. United Kingdom Protein Chips Market Size in USD Million (2021-2030)
      • 7.4.2.4. Italy Protein Chips Market Size in USD Million (2021-2030)
      • 7.4.2.5. Spain Protein Chips Market Size in USD Million (2021-2030)
      • 7.4.2.6. Rest of Europe Protein Chips Market Size in USD Million (2021-2030)
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China Protein Chips Market Size in USD Million (2021-2030)
      • 7.4.3.2. Japan Protein Chips Market Size in USD Million (2021-2030)
      • 7.4.3.3. India Protein Chips Market Size in USD Million (2021-2030)
      • 7.4.3.4. Australia Protein Chips Market Size in USD Million (2021-2030)
      • 7.4.3.5. South Korea Protein Chips Market Size in USD Million (2021-2030)
      • 7.4.3.6. Rest of Asia-Pacific Protein Chips Market Size in USD Million (2021-2030)
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. Middle East Protein Chips Market Size in USD Million (2021-2030)
      • 7.4.4.2. Africa Protein Chips Market Size in USD Million (2021-2030)
      • 7.4.4.3. South America Protein Chips Market Size in USD Million (2021-2030)

8. Protein Chips Market Company and Product Profiles

  • 8.1. Agilent Technologies, Inc.
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. RayBiotech, Inc.
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Sengenics Corporation LLC.
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. CDI Labs.
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Creative Biolabs
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Proteintech Group, Inc
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. RayBiotech Life Inc.
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. QUOTIENT LIMITED
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. PerkinElmer Inc.
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Merck KGAA
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Illmina Inc.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Arrayit Corporation
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Spectrum Solutions
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. ACROBiosystems
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Sengenics Corporation LLC
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제